Switches of tyrosine-kinase inhibitors in chronic phase of chronic myeloid leukemia in real life.

Authors :: Norwood J
Pastoret C
Luycx O
Le Coz MF
Moreau P
Trebouet A
Niault M
Launay V
Allangba O
Bareau B
Doncker V
Grulois I
Jacomy D
Le Dû K
Henry C
Le Pabic E
Boulland ML
Fest T
Lamy T
Escoffre-Barbe M
Source :: American journal of hematology [Am J Hematol] 2018 Oct; Vol. 93 (10), pp. E329-E331. Date of Electronic Publication: 2018 Sep 30.
Publication Year :: 2018

Subjects :: Adult
Aged
Aged, 80 and over
Drug Resistance, Neoplasm
Female
Follow-Up Studies
Humans
Imatinib Mesylate therapeutic use
Male
Middle Aged
Retrospective Studies
Survival Analysis
Treatment Outcome
Young Adult
Antineoplastic Agents therapeutic use
Drug Substitution
Leukemia, Myeloid, Chronic-Phase drug therapy
Protein Kinase Inhibitors therapeutic use

Full Text Access

Tools